TGF-β is clearly critical for limiting infection-associated inflammation, but the powerful immunosuppressive effects TGF-β exerts can be exploited by pulmonary pathogens, with the timing and extent of TGF-β inhibition impacting infection outcome. The gene discussed is TGFB1; the disease is infection.